Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries (Q85208142)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25168369%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

meta-analysis

0 references

title

Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25168369%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

Helicobacter pylori infectious disease

1 reference

Zhicheng Zhao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25168369%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Yuhong Li

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25168369%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Shengxin Liu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25168369%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Weihua Fu

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25168369%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

29 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25168369%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25168369%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25168369%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

12217-12224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25168369%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25168369%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-014-2530-8

15 February 2020

exact match

0 references

cites work

CagA seropositivity associated with development of gastric cancer in a Japanese population

1 reference

12 December 2020

Helicobacter pylori and atrophic gastritis: importance of the cagA status

1 reference

12 December 2020

Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country

1 reference

12 December 2020

Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study

1 reference

12 December 2020

The diagnostic odds ratio: a single indicator of test performance

1 reference

12 December 2020

Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs

1 reference

12 December 2020

Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach

1 reference

12 December 2020

Meta-analysis of the relationship between cagA seropositivity and gastric cancer.

1 reference

12 December 2020

Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

1 reference

12 December 2020

Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population

1 reference

12 December 2020

Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute

1 reference

12 December 2020

CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea

1 reference

12 December 2020

Epidemiology of gastric cancer

1 reference

12 December 2020

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

1 reference

12 December 2020

Estimates of cancer incidence in China for 2000 and projections for 2005.

1 reference

12 December 2020

Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data

1 reference

12 December 2020

Early diagnosis of early gastric cancer

1 reference

12 December 2020

Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori

1 reference

12 December 2020

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

1 reference

12 December 2020

Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion.

1 reference

12 December 2020

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

12 December 2020

Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests.

1 reference

12 December 2020

Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults

1 reference

12 December 2020

Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China

1 reference

12 December 2020

Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection

1 reference

12 December 2020

Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries.

1 reference

12 December 2020